NEW YORK (Reuters Health) - After surgery for early-stage breast cancer, women may be treated with tamoxifen for 5 years. After that point, treatment with Aromasin significantly improves survival, according to a new study.>>> Discuss This Story
NEW YORK (Reuters Health) - After surgery for early-stage breast cancer, women may be treated with tamoxifen for 5 years. After that point, treatment with Aromasin significantly improves survival, according to a new study.>>> Discuss This Story
